854 studies found for:    Open Studies | "Hypoglycemic Agents"
Show Display Options
Rank Status Study
21 Recruiting Trial to Compare NNC0123-0000-0338 in a Tablet Formulation and Insulin Glargine in Subjects With Type 2 Diabetes Currently Treated With Oral Antidiabetic Therapy
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Interventions: Drug: insulin 338 (GIPET I);   Drug: insulin glargine;   Drug: placebo
22 Recruiting Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin glargine U300 HOE901;   Drug: Insulin glargine HOE901
23 Recruiting A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Ertugliflozin;   Drug: Placebo
24 Recruiting A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Interventions: Drug: insulin detemir;   Drug: insulin NPH
25 Recruiting Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.
Conditions: Psoriasis;   Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin;   Drug: Gliclazide;   Drug: Sitagliptin matched placebo;   Drug: Gliclazide matched placebo capsule
26 Unknown  Observational Registry for Basal Insulin Treatment Study (ORBIT)
Condition: Diabetes
Intervention:
27 Recruiting Linagliptin Inpatient Trial
Condition: Type 2 Diabetes
Interventions: Drug: Linagliptin;   Drug: Basal Bolus;   Drug: Linagliptin + 50% Glargine dose on discharge;   Drug: Linagliptin + 80% Glargine
28 Not yet recruiting A Study to Compare Insulin Intensification of Biphasic Insulin Aspart 30 and Insulin Analogues (Insulin Glargine and Insulin Aspart) in Insulin naïve Type 2 Diabetic Patients
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Interventions: Drug: biphasic insulin aspart 30;   Drug: insulin glargine;   Drug: insulin aspart
29 Recruiting Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)
Conditions: Type 2 Diabetes Mellitus;   Cardiovascular Disease
Interventions: Drug: Liraglutide;   Drug: Sitagliptin
30 Not yet recruiting Treatment of Recurrent Brain Tumors: Metabolic Manipulation Combined With Radiotherapy
Condition: Brain Neoplasms
Interventions: Radiation: Partial brain re-irradiation.;   Drug: Metformin;   Behavioral: low carbohydrate diet
31 Recruiting Comparison of Two Titration Programs of Adding Insulin Detemir to OADs in Poorly Controlled Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Behavioral: Active  titration algorithm;   Behavioral: Usual titration algorithm
32 Recruiting The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent Claudication
Conditions: Peripheral Arterial Disease;   Intermittent Claudication
Interventions: Drug: Metformin;   Drug: Placebo
33 Unknown  Effects of Alogliptin on Pancreatic Beta Cell Function
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Alogliptin;   Drug: Metformin 750 mg
34 Recruiting Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia
Conditions: Type 1 Diabetes Mellitus;   Nocturnal Hypoglycemia;   Recurrent Severe Hypoglycaemia
Interventions: Drug: Insulin aspart/glargine;   Drug: Insulin aspart/degludec
35 Recruiting The Practical Evidence of Antidiabetic Combination Therapy in Korea
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: alogliptin;   Drug: Pioglitazone;   Drug: alogliptin + pioglitazone
36 Unknown  The Effects of Hypolipemic and Antidiabetic Treatment on Cytokines
Conditions: Diabetes;   Dyslipidemia;   Inflammation;   Cytokines
Intervention: Drug: Metformin 1000mg, simvastatin 10mg and fenofibrate 100mg
37 Recruiting Hypoglycemia and Autonomic Nervous System Function
Condition: Hypoglycemia
Interventions: Drug: Eplerenone;   Drug: Placebo
38 Unknown  Shiga Progression of Diabetes, Nephropathy and Retinopathy
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Pioglitazone add on to SU or biguanide;   Drug: SU or Biguanide
39 Unknown  An Open-randomized, Balanced, Crossover Bioequivalence Study to Compare One MR Tablet of 60 mg Gliclazide and Two MR Tablets of 30 mg Gliclazide in Healthy Subjects
Conditions: Hyperglycemia;   Diabetes
Intervention:
40 Recruiting Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Liraglutide;   Drug: Placebo;   Drug: Mixed Meal Tolerance Test with paracetamol

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years